Freestone Grove Partners LP Makes New $19 Million Investment in Acadia Healthcare Company, Inc. $ACHC

Freestone Grove Partners LP acquired a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in the second quarter, Holdings Channel reports. The fund acquired 643,486 shares of the company’s stock, valued at approximately $19,002,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. EverSource Wealth Advisors LLC increased its holdings in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Allworth Financial LP bought a new stake in shares of Acadia Healthcare in the second quarter valued at approximately $45,000. Wells Fargo & Company MN grew its position in Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock worth $32,000 after buying an additional 1,510 shares in the last quarter. Global Retirement Partners LLC bought a new position in Acadia Healthcare during the 2nd quarter worth $68,000. Finally, Quantbot Technologies LP bought a new position in Acadia Healthcare during the 2nd quarter worth $88,000.

Wall Street Analyst Weigh In

ACHC has been the subject of a number of recent analyst reports. TD Cowen upped their target price on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Guggenheim boosted their price target on Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. UBS Group increased their price objective on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Barclays raised their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a report on Thursday, July 30th. Finally, Jefferies Financial Group upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $29.85.

Acadia Healthcare Trading Down 1.2%

Shares of ACHC opened at $30.22 on Friday. The company has a debt-to-equity ratio of 1.20, a quick ratio of 1.57 and a current ratio of 1.57. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $35.83. The firm has a market cap of $2.81 billion, a price-to-earnings ratio of -2.43, a PEG ratio of 9.85 and a beta of 0.64. The business’s fifty day moving average is $30.39 and its 200-day moving average is $26.04.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The business had revenue of $865.84 million for the quarter, compared to analyst estimates of $844.19 million. During the same period last year, the firm posted $0.83 earnings per share. Acadia Healthcare’s revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.